Quantcast

Latest RNA Stories

2014-09-19 16:24:35

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j8jfz4/global) has announced the addition of the "Global Transcriptomics Market 2014-2018" [http://www.researchandmarkets.com/research/j8jfz4/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Transcriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of...

2014-09-18 08:29:39

MILFORD, Mass., Sept. 18, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of RNA viruses, today announced a research collaboration with the National Institutes of Health (NIH) for animal testing of the Company's lead compound, SB 9200, against multiple viral pathogens, classified as "Special Pathogens," against which currently there are no effective antiviral therapies. SB 9200, derived...

2014-09-18 08:29:06

MARLBOROUGH, Mass., Sept. 18, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the 7(th) Annual BioPharm America(TM) Conference on Wednesday, September 24, 2014 at 11:20 a.m. EDT. Dr....

2014-09-17 08:29:00

Patents granted by the United States Patent and Trademark Office and European Patent Office and a notice of allowance from the Japanese Patent Office broaden the breadth of the Company's delivery technology platform MARLBOROUGH, Mass., Sept. 17, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies,...

2014-09-15 12:22:43

IRVINE, Calif., Sept. 15, 2014 /PRNewswire/ -- Zymo Research Corp., has announced the release of a new viral transport solution for safe ambient temperature storage and transport of infectious biological specimens prior to molecular testing. Importantly, the infectivity of agents in such samples is completely inactivated by the solution while maintaining the integrity of the viral nucleic acids for subsequent analyses. With the dire news of the recent Ebola epidemic in West Africa...

2014-09-11 23:02:52

New research study “DNA and RNA Sample Preparation Markets: Market Developments, Growth Areas and Opportunities” worked out by Biopharm Reports is now available at MarketPublishers.com. London, UK (PRWEB) September 11, 2014 Extraction methods exploited to isolate DNA and RNA are key to the majority of studies performed in the molecular biology field. These molecules are isolated before the downstream process for a broad scope of applications, from fundamental research to routine...

2014-09-09 20:25:09

LAS VEGAS, Sept. 9, 2014 /PRNewswire/ -- Altogen Biosystems (www.altogen.com), a manufacturer of reagents for biological research, offers a broad range of animal in vivo transfection kits targeted to a specific tissue type. The Company provides transfection reagents that enable tissue-targeted delivery of plasmid DNA expression vectors, small RNA therapeutic molecules (siRNA and microRNA), and proteins (http://www.altogen.com/mirna.php). In vivo transfection kits are laboratory tested...

2014-09-09 12:28:35

PORTLAND, Oregon, September 9, 2014 /PRNewswire/ -- A new report by Allied Market Research, titled "RNA Therapeutics Market (technology, applications, end user and geography) - Industry Analysis and Forecast, 2013 - 2020", suggests that the RNA Based Therapeutics Market would reach $1.2 billion by 2020 registering a CAGR of 28.4% during 2014 - 2020. Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain...

2014-09-08 08:29:41

BERGEN, Norway, September 8, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the United States Patent and Trademark Office (USPTO) has issued United States Patent 8,735,064 covering a method for creating and identifying functional interference RNA (RNAi) molecules (1). RNAis are recombinant nucleic acid molecules that have the ability to specifically down-regulate an expressed target gene in vivo....

2014-08-21 23:14:52

InSilico Medicine, Inc. officially announces OncoFinder for effective pathway analysis and drug screening. Baltimore, MD 21218 (PRWEB) August 21, 2014 InSilico Medicine, a Baltimore-based company dedicated to aging interventions and addressing the challenges of a rapidly aging population, proposes a new concept, OncoFinder, for signalome-wide pathway analysis. This new method allows for accurate and robust cross-platform analysis of gene expression data obtained using high-throughput...


Latest RNA Reference Libraries

Brief Introduction To DNA Probes
2014-01-12 00:00:00

DNA probes help scientists to detect a specific gene in a long DNA sequence. According to Dr. Michael A. Pfaller, DNA probes are “single-stranded pieces of nucleic acid, labeled with a specific tracer (isotope, enzyme, or chromophore), that will hydrogen bond (hybridize) with complementary single-stranded pieces of DNA (or RNA) under the appropriate conditions of pH, temperature, and iconic strength.” The Foundation for Genomics and Population Health website has a helpful video about...

Caenorhabditis elegans
2014-01-12 00:00:00

Caenorhabditis elegans is a species of parasitic roundworm in the Nematoda phylum. It can be found in temperate regions, in many different areas of the world. It prefers to reside in nutrient rich soils. Its scientific name is derived from the Greek terms Caeno, meaning recent, rhabditis, meaning rod-like, and the Latin term elegans, which means elegant. It was first named by Maupas in 1900, but was not classified in the Caenorhabditis subgenus until 1952 by Osche. Caenorhabditis elegans...

Proceedings of the National Academy of Sciences
2012-05-29 11:19:42

The Proceedings of the National Academy of Sciences of the United States of America (PNAS) is a peer-reviewed scientific journal established in 1914 as the official journal of the US National Academy of Sciences. The first managing editor of the journal was mathematician Edwin Bidwell Wilson. As of May 2012, the editor-in-chief is Inder M. Verma. PNAS is published weekly in print, and daily online in PNAS Early Edition. The first issue of PNAS was published in 1915, and the journal...

Biophysical Journal
2012-05-28 10:08:02

The Biophysical Journal is a peer-reviewed scientific journal published biweekly by Cell Press on behalf of the Biophysical Society. It was established in 1960. The editor-in-chief is Edward Egelman. It covers all aspects of biophysics.  It is the leading international journal for original research in molecular, cellular, and system biophysics. Modern biophysics is a broad and rapidly advancing field encompassing the study of biological structures with a focus on mechanisms at the...

More Articles (5 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.